Company news

Share this article:
Abbott Laboratories has announced plans to acquire Ibis Biosciences, the molecular diagnostics division of Isis Pharmaceuticals. Abbott invested $40 million in the company earlier this year, and will purchase all remaining equity for $175 million. 
 
Wyeth Pharmaceuticals has announced the acquisition of Thiakis Limitied, a privately held biotech based in the UK. Thiakis lead product candidate, TKS 1225, will potentially treat obesity and other co-morbidities. 
 
New England-based pharma research firm Charles River Laboratories will invest $20 million and create 60 jobs by expanding its Charleston, SC, operations.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

DOJ closes Brilinta investigation

AstraZeneca announced the end of the investigation Tuesday.

Doctors back unique biosimilar names

A host of doctors has asked FDA Commissioner Margaret Hamburg to back a naming convention that would require biologics and biosimilars to have different names.

Roche has no rights to Sovaldi, panel rules

Despite a collaboration with original Sovaldi owner Pharmasset in 2004, a panel ruled Roche has no rights to HCV treatment Sovaldi.